LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Liquidia Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$34.13−0.22 (-0.64%)
Close on Oct 19, 2026
- Market cap
- $3.46B
- P/E (TTM)
- 24.6
- Dividend yield
- –
Liquidia statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Liquidia | Industry median |
|---|---|---|
| Market Cap | $3.05B | $166.30M |
| Enterprise Value | $2.77B | $87.12M |
| PE Ratio | 24.55 | 19.67 |
| PS Ratio | 6.78 | 3.60 |
| PB Ratio | 15.66 | 2.03 |
| P/TBV Ratio | 16.22 | 2.31 |
| P/FCF Ratio | 20.27 | 17.44 |
| P/OCF Ratio | 18.22 | 13.32 |
Enterprise value
| Measure | Liquidia | Industry median |
|---|---|---|
| EV / Sales | 6.14 | 2.43 |
| EV / EBITDA | 16.30 | 14.69 |
| EV / EBIT | 16.44 | 18.47 |
| EV / FCF | 18.39 | 20.97 |
Income (trailing twelve months)
| Measure | Liquidia | Industry median |
|---|---|---|
| Revenue | $450.91M | $57.94M |
| Operating Income | $168.58M | -$21.49M |
| Net Income | $138.61M | -$22.46M |
| EBITDA | $169.99M | -$17.14M |
| EPS (Diluted) | $1.39 | -$0.83 |
Margins
| Measure | Liquidia | Industry median |
|---|---|---|
| Operating Margin | 37.4% | -44.5% |
| Profit Margin | 30.7% | -39.2% |
| EBITDA Margin | 37.7% | -31.3% |
| FCF Margin | 33.4% | -8.85% |
Returns
| Measure | Liquidia | Industry median |
|---|---|---|
| Return on Equity (ROE) | 131.8% | -53.2% |
| Return on Assets (ROA) | 35.6% | -41.0% |
| Return on Capital Employed (ROCE) | 50.7% | -38.0% |
Growth
| Measure | Liquidia | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 2233.7% | 6.01% |
| Revenue Growth (3Y CAGR) | 115.0% | 2.25% |
| Revenue Growth (5Y CAGR) | 192.5% | 6.42% |
Balance sheet
| Measure | Liquidia | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $284.18M | $62.64M |
| Net Cash (Debt) | $284.18M | $15.77M |
| Net Cash Per Share | $3.17 | $0.66 |
| Equity (Book Value) | $195.11M | $48.61M |
| Book Value Per Share | $2.18 | $1.36 |
| Tangible Book Value | $188.37M | $23.01M |
| Working Capital | $248.41M | $75.09M |
Financial position
| Measure | Liquidia | Industry median |
|---|---|---|
| Current Ratio | 2.31 | 3.30 |
| Quick Ratio | 2.07 | 2.39 |
| Interest Coverage | 6.33 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Liquidia | Industry median |
|---|---|---|
| Operating Cash Flow | $167.71M | -$12.39M |
| Capital Expenditures | -$17.01M | -$1.07M |
| Free Cash Flow | $150.69M | -$20.34M |
| FCF Per Share | $1.68 | -$0.42 |
Efficiency
| Measure | Liquidia | Industry median |
|---|---|---|
| Asset Turnover | 1.16 | 0.38 |
| Revenue Per Employee | $2.09M | $398.96K |
| Profits Per Employee | $641.69K | -$705.27K |
| Employee Count | 216 | 74 |
Dividends and yields
| Measure | Liquidia | Industry median |
|---|---|---|
| Earnings Yield | 4.54% | -22.8% |
| FCF Yield | 4.93% | -9.02% |
Shares
| Measure | Liquidia | Industry median |
|---|---|---|
| Shares Outstanding | 89,508,900 | 58,139,000 |
| Shares Change (YoY) | 12.7% | 11.1% |
| Shares Change (QoQ) | 0.90% | 0.54% |
| Float | 71,398,000 | 49,154,900 |
| Shares Held by Insiders | 20.2% | 11.6% |
| Shares Held by Institutions | 81.1% | 59.4% |
Scores
| Measure | Liquidia | Industry median |
|---|---|---|
| Graham Number | $8.26 | $17.04 |
| Graham Upside | -75.8% | -44.3% |
| Altman Z-Score | 6.77 | -0.27 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Liquidia's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.